Home » Topics » Disease categories and therapies » Ear, nose and throat

Ear, nose and throat
RSS

Auris Medical advances phase IIb trial of AM-111 for acute sensorineural hearing loss

Jan. 24, 2011

Neramexane mesilate is safe and well tolerated in subjects with tinnitus

Jan. 18, 2011

Auris Medical advances phase IIb trial of AM-111 in acute sensorineural hearing loss

Nov. 26, 2010

GenVec achieves milestone in collaboration with Novartis

Sep. 15, 2010

Otonomy closes Series B financing

Sep. 1, 2010

Topical nitroglycerin improves symptoms of chondrodermatitis nodularis helicis

Aug. 16, 2010

GenVec and Novartis expand collaboration on hearing loss and balance disorders

Aug. 9, 2010

Otonomy secures funds to advance OTO-104 and OTO-203

June 16, 2010

Otonomy receives FDA clearance for trial in Meniere's disease

Feb. 18, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 12, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 12, 2025.
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
CTAD 2025: The challenges of combination therapies for dementia
BioWorld Science
At the Clinical Trials on Alzheimer’s Disease 2025 meeting, a panel of experts discussed the need for developing combination therapies for the complex diseases...
DEE-lightful: Praxis’ phase II results allow stock to flex its muscle
BioWorld
Positive efficacy results led to Praxis Precision Medicines Inc.’s phase II Embold study in developmental and epileptic encephalopathies (DEEs) being halted...